Some patients find it helpful to inject in the evening so the initial peak occurs during sleep, reducing awareness of mild GI discomfort
This creates maximum precision for small doses, making it ideal for microdosing protocols or researchers who prioritize measurement accuracy above all else
Phase 2 data showed 22.8% weight loss at 8 mg versus 24.2% at 12 mg, with noticeably fewer GI side effects
CrossRef Diabetes: A comprehensive review of the Indian landscape in contrast with global trends Nidhi Singh Rana, Naveen Kumar Vishvakarma, Subash Chandra Sonkar, Mirza Masroor Ali Beg World Journal of Diabetes.2026;[Epub] CrossRef Elevated Systemic Immune-Inflammation Index is Associated with Gestational Diabetes Mellitus: A Multicenter Retrospective Studies Jingyang Li, Qiong Li, Yixuan Zhang, Xiaohu Chen, Chunyi Zhang, Yu Chen, Ying Gu, Chaoyan Yue Journal of Inflammation Research.2026